Press release2017.09.25

Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation

PRESS RELEASE “Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation”

Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation

ImmuniT Research Inc.

〒105-0004 東京都港区新橋1-1-13
アーバンネット内幸町ビル3階